Why is National Health Investors, Inc. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 9.57%
2
Poor long term growth as Operating profit has grown by an annual rate of -3.24%
3
Flat results in Jun 25
- NO KEY NEGATIVE TRIGGERS
4
With ROE of 10.44%, it has a fair valuation with a 2.37 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.11%, its profits have risen by 10.7% ; the PEG ratio of the company is 4.4
- At the current price, the company has a high dividend yield of 461.6
5
Underperformed the market in the last 1 year
- The stock has generated a return of 2.11% in the last 1 year, much lower than market (S&P 500) returns of 14.11%
How much should you hold?
- Overall Portfolio exposure to National Health Investors, Inc. should be less than 10%
- Overall Portfolio exposure to Realty should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Realty)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is National Health Investors, Inc. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
National Health Investors, Inc.
17.47%
0.89
19.69%
S&P 500
17.45%
0.70
20.15%
Quality key factors
Factor
Value
Sales Growth (5y)
1.79%
EBIT Growth (5y)
-3.17%
EBIT to Interest (avg)
5.22
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
115.16%
Pledged Shares
0
Institutional Holding
81.60%
ROCE (avg)
13.88%
ROE (avg)
9.57%
Valuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
2.44
EV to EBIT
18.42
EV to EBITDA
13.14
EV to Capital Employed
2.46
EV to Sales
10.22
PEG Ratio
2.61
Dividend Yield
435.03%
ROCE (Latest)
13.35%
ROE (Latest)
10.17%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bullish
Technical Movement
9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 228.4 MM
ROCE(HY)
Highest at 10.87%
CASH AND EQV(HY)
Highest at USD 100.27 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 69.38 %
DEBTORS TURNOVER RATIO(HY)
Highest at 1.16 times
DIVIDEND PER SHARE(HY)
Highest at USD 1.16
-3What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 9.35% (YoY
PRE-TAX PROFIT(Q)
Lowest at USD 30.63 MM
NET PROFIT(Q)
Lowest at USD 31.02 MM
Here's what is working for National Health Investors, Inc.
Operating Cash Flow
Highest at USD 228.4 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 100.27 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 69.38 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 1.16 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Dividend per share
Highest at USD 1.16
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Depreciation
Highest at USD 20.94 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for National Health Investors, Inc.
Pre-Tax Profit
Lowest at USD 30.63 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD 31.02 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Raw Material Cost
Grown by 9.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






